Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
Ghent, BELGIUM, Aug. 03, 2021 (GLOBE NEWSWIRE) -- Press release - regulated information Information on the total number of voting rights and shares Ghent, BELGIUM – 3 August 2021 – In accordance...
-
Ghent, BELGIUM, Aug. 02, 2021 (GLOBE NEWSWIRE) -- This announcement is not an offer to invest in the shares (the “Shares”) of Biotalys. An investment in the Shares can only be based on the...
-
Ghent, July 15, 2021 (GLOBE NEWSWIRE) -- Press release - regulated information Publication of transparency notifications(Article 14(1) of the Law of 2 May 2007 on the disclosure of large...
-
Ghent, BELGIUM, July 06, 2021 (GLOBE NEWSWIRE) -- Press release - regulated information Biotalys Appoints Markus Heldt as Independent Director Seasoned agricultural industry leader appointed to...
-
Ghent, BELGIUM, July 05, 2021 (GLOBE NEWSWIRE) -- Press release - regulated information Information on the total number of voting rights and shares Ghent, BELGIUM – 5 July 2021 – In accordance...
-
Ghent, BELGIUM , July 01, 2021 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, SWITZERLAND, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY...
-
Ghent, BELGIUM, July 01, 2021 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, SWITZERLAND, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY...
-
Ghent, BELGIUM, June 29, 2021 (GLOBE NEWSWIRE) -- This announcement is not an offer to invest in the shares (the “Shares”) of Biotalys. An investment in the Shares can only be based on the...
-
Ghent, BELGIUM , June 23, 2021 (GLOBE NEWSWIRE) -- NOT FOR DISTRIBUTION, PUBLICATION OR RELEASE TO OR WITHIN THE UNITED STATES OF AMERICA, CANADA, SWITZERLAND, JAPAN, SOUTH AFRICA, AUSTRALIA OR ANY...
-
Ghent, Belgium, June 17, 2021 (GLOBE NEWSWIRE) -- Biotalys’ ongoing trial program demonstrates strong potential of its new generation protein-based biocontrols Company receives favorable feedback...